|
CN112165948A
|
|
Polysaccharides for treating ocular conditions
|
|
WO2017148951A1
|
|
Gene signature for the prognosis of dry eye disease
|
|
WO2017148950A1
|
|
Gene signature for the detection of vernal keratoconjunctivitis
|
|
HUS1700007I1
|
|
Compositions containing quaternary ammonium compounds
|
|
US2016331683A1
|
|
Water-in-oil type emulsion for treating a disease of the eye
|
|
EP3011959A1
|
|
Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha
|
|
AU2014201978A1
|
|
Compositions containing quaternary ammonium compounds
|
|
JP2014028865A
|
|
Process for manufacturing ophthalmic oil-in-water emulsions
|
|
AU2007336206A1
|
|
Process for manufacturing ophthalmic oil-in-water emulsions
|
|
AU2006301493A1
|
|
Ophthalmic emulsions containing prostaglandins
|
|
EP2322183A1
|
|
Use of prodrugs for ocular intravitreous administration
|
